eLaws | eCases | United States Code | Federal Courts |

McKesson Corporation - Comment

Document ID: FDA-2010-N-0465-0005
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 22 2010, at 12:00 AM Eastern Standard Time
Date Posted: December 21 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: September 22 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: November 22 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80ba11a6
View Document:

This is comment on Notice

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study; Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements, etc.

View Comment

Attached are McKesson Corporation's comments to the FDA on Direct-to-Consumer Prescription Drug Advertisements.

Attachments:

McKesson Corporation - Comment

Title:
McKesson Corporation - Comment

View Attachment:

View as format pdf

Related Comments

View All

Total: 6

Anonymous - Comment
Public Submission Posted: 10/12/2010 ID: FDA-2010-N-0465-0002

Comment Period Closed
Nov 22,2010 11:59 PM ET

Bausch+Lomb - Comment
Public Submission Posted: 12/21/2010 ID: FDA-2010-N-0465-0004

Comment Period Closed
Nov 22,2010 11:59 PM ET

McKesson Corporation - Comment
Public Submission Posted: 12/21/2010 ID: FDA-2010-N-0465-0005

Comment Period Closed
Nov 22,2010 11:59 PM ET

Community Catalyst - Comment
Public Submission Posted: 12/21/2010 ID: FDA-2010-N-0465-0006

Comment Period Closed
Nov 22,2010 11:59 PM ET

Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Public Submission Posted: 12/21/2010 ID: FDA-2010-N-0465-0007

Comment Period Closed
Nov 22,2010 11:59 PM ET